Levofloxacin Injection, Solution
Product Images NDC 36000-045
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 36000-045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 02)
Figure 3 (8e9a2fd5 Afc9 473d A9fd 17db184392fb 03)
This is likely a prescription medication in tablet form with a strength of 500 mg, to be taken orally. The second line may indicate dosing information. The third line appears to refer to plasma concentration, which may be relevant for monitoring the medication's effectiveness and potential side effects. However, without further context or information, it is difficult to provide a more specific description or identification of the medication.*
Carton Label For 500 mg/20 mL (8e9a2fd5 Afc9 473d A9fd 17db184392fb 04)
This is a description for a medication with the name "Levofloxacin". Each vial contains a concentrated solution of 500 mg Levofloxacin in 20 mL of water for injection. It may contain some diluted Hydrochloric Acid and/or Sodium Hydroxide for pH adjustment, the pH range being 3.8-5.8. This medication must not be infused directly, instead, the vial contents should be further diluted with an appropriate solution before intravenous administration. The insert provides the intravenous solutions' preparation, stability, storage, compatibility, and the usual adult dosage of 500 mg Levofloxacin. The medication should be stored at 20°C-25°C (68-77°F) until ready to use. Dispense the accompanying Medication Guide to each patient. The medication is for Rx only. The batch number is 1000012963. The medication was manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015 USA, and by Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India.*
Plastic Bag For 250 mg/50 mL (8e9a2fd5 Afc9 473d A9fd 17db184392fb 05)
This is a description of Baxter AIN00233 50 mL levofloxacin injection in 5% Dextrose. Each 50 mL contains 250 mg of levofloxacin (5 mg/mL) in 5% dextrose. It should be infused over 60 minutes and should not be added or infused simultaneously through the same intravenous line with other additives. Any unused portion should be discarded. It is recommended that the accompanying Medication Guide is dispensed to each patient. The solution should be clear and the container should be undamaged before use. The batch number is AAAAAAAA and the expiration date is CCCCCCCC. It was manufactured by Baxter Pharmaceuticals India Private Ltd in Ahmedabad 382213, India and distributed by Baxter Healthcare Corporation in Deerfield, IL, USA.*
Plastic Bag For 500 mg/ 100 mL (8e9a2fd5 Afc9 473d A9fd 17db184392fb 06)
This is a description of a medication called Levofloxacin Injection. It comes in a 100 mL container and contains 500 mg of Levofloxacin in a solution of 5% dextrose. This medication is administered intravenously over 60 minutes and should be used immediately after it's removed from the overwrap. The container should not be used in series connection and the solution should be clear before usage. The usual adult dosage can be found in the insert and any unused portion of the medication should be discarded. The container closure is not made with natural rubber latex. The medication is manufactured by Baxter Pharmaceuticals India Private Ltd and batch information is provided. The accompanying medication guide should be dispensed to each patient.*
Plastic Bag For 750 mg/ 150 mL (8e9a2fd5 Afc9 473d A9fd 17db184392fb 07)
Levofloxacin is an intravenous antibiotic used to treat various infections caused by bacteria. This drug is dispensed in a 150 mL single-use container and is to be used immediately after opening. The container contains a dilute solution equivalent to 750 mg of levofloxacin (5 mg/mL) in 5% dextrose. The infusion should be given over 90 minutes and no further dilution is necessary. Any unused portion should be discarded. The accompanying medication guide should be dispensed to each patient. The solution should only be used if the container is undamaged, and the solution is clear. The container is manufactured by Baxter Healthcare Corporation and is latex-free.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.